Product name:Intedanib
CAS: 656247-17-5
Molecular Formula: C31H33N5O4
Molecular Weight: 539.62482
Product description:An oral dosing of triple tyrosine kinase inhibitors, targets including platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), also can inhibit the MAPK and Akt activation. At present is mainly used for tumor treatment, such as colorectal cancer, ovarian cancer and multiple myeloma. Studies of respiratory disorders centered advanced non-small cell lung cancer (NSCLC) and idiopathic pulmonary fibrosis (IPF) in clinical practice.